前哨淋巴结活检与选择性颈清扫在cN0口腔鳞癌中的系统综述与荟萃分析
该系统综述与荟萃分析纳入6项前瞻性研究,比较前哨淋巴结活检(SLNB)与选择性颈清扫(END)在临床N0(cN0)口腔鳞状细胞癌中的疗效。结果显示两组区域复发、5年无病生存和5年总生存均无显著差异,但SLNB组不良事件显著更少。结论认为SLNB肿瘤学预后不劣于END,且可减少副作用和不必要的手术。
要点
- SLNB与END在cN0口腔鳞癌中区域复发风险相当(RR=0.99)。
- 两组5年无病生存和总生存无显著差异。
- SLNB组不良事件显著少于END组(RR=0.12)。
核心结论
- 对于cN0口腔鳞状细胞癌患者,SLNB的肿瘤学预后与END相当,且显著减少不良事件和不必要的手术。
研究设计与样本
- 系统综述与荟萃分析,纳入6项前瞻性研究,比较SLNB与END在cN0口腔鳞癌患者中的效果。
主要发现
- 区域复发风险比RR=0.99(95%CI 0.58-1.70)。
- 5年无病生存RR=0.99(95%CI 0.87-1.11)。
- 5年总生存RR=1.01(95%CI 0.90-1.13)。
- 不良事件RR=0.12(95%CI 0.02-0.70),SLNB组更少。
临床怎么用
- SLNB可作为cN0口腔鳞癌患者END的替代选择,以减少手术并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sentinel lymph node biopsy (SLNB) is an emerging strategy for managing early-stage oral squamous cell carcinoma (SCC) with a clinically N0 (cN0) neck. However, the role of SLNB in this scenario is debatable. Herein, relevant literature was systematically reviewed, and a meta-analysis was performed to evaluate the potential dividends of SLNB compared to elective neck dissection (END) for these patients. The meta-analysis, including six prospective studies, showed comparable results of the two management strategies in terms of regional recurrence (risk ratio [RR] = 0.99; 95% confidence interval [CI], 0.58-1.70), 5-year disease-free survival (RR = 0.99; 95% CI, 0.87-1.11), and 5-year overall survival (RR = 1.01; 95% CI, 0.90-1.13). Fewer adverse events occurred in the SLNB arm than in the END arm (RR = 0.12; 95% CI, 0.02-0.70). Overall, SLNB results in as favorable an oncologic prognosis for patients with cN0 oral SCC as END, while significantly lessening side effects and unnecessary surgeries.
引用
- Ding Z, Li Y, Pan X, et al. Sentinel lymph node biopsy versus elective neck dissection in squamous cell carcinoma of the oral cavity with a clinically N0 neck: Systematic review and meta-analysis of prospective studies. Head Neck. 2021. PMID: 34245070. doi:10.1002/hed.26803
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。